Rafael Dal‐Ré

3.3k total citations
162 papers, 2.0k citations indexed

About

Rafael Dal‐Ré is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Statistics, Probability and Uncertainty. According to data from OpenAlex, Rafael Dal‐Ré has authored 162 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Public Health, Environmental and Occupational Health, 61 papers in Economics and Econometrics and 37 papers in Statistics, Probability and Uncertainty. Recurrent topics in Rafael Dal‐Ré's work include Health Systems, Economic Evaluations, Quality of Life (56 papers), Ethics in Clinical Research (48 papers) and Meta-analysis and systematic reviews (35 papers). Rafael Dal‐Ré is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (56 papers), Ethics in Clinical Research (48 papers) and Meta-analysis and systematic reviews (35 papers). Rafael Dal‐Ré collaborates with scholars based in Spain, United States and United Kingdom. Rafael Dal‐Ré's co-authors include John P. A. Ioannidis, Manuel Garcı́a-Losa, Carmen Ayuso, Perrine Janiaud, Xavier Badía, Arthur L. Caplan, Ana Marušić, Søren Holm, José M. Millán and Joseph S. Ross and has published in prestigious journals such as JAMA, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Rafael Dal‐Ré

153 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael Dal‐Ré Spain 24 506 335 300 280 225 162 2.0k
Catherine D. DeAngelis United States 23 486 1.0× 386 1.2× 227 0.8× 759 2.7× 279 1.2× 98 2.4k
Iain Chalmers United Kingdom 35 1.5k 2.9× 486 1.5× 734 2.4× 738 2.6× 994 4.4× 113 5.2k
Dale McLerran United States 29 733 1.4× 211 0.6× 33 0.1× 600 2.1× 320 1.4× 46 3.2k
Aneesa Motala United States 23 461 0.9× 155 0.5× 100 0.3× 441 1.6× 224 1.0× 91 2.1k
Eugène van Puijenbroek Netherlands 33 475 0.9× 641 1.9× 54 0.2× 64 0.2× 331 1.5× 248 4.8k
Antje Timmer Germany 29 497 1.0× 156 0.5× 260 0.9× 188 0.7× 804 3.6× 79 3.7k
Kirsty Loudon United Kingdom 13 576 1.1× 577 1.7× 497 1.7× 646 2.3× 196 0.9× 28 2.2k
Allen F. Shaughnessy United States 26 832 1.6× 273 0.8× 275 0.9× 860 3.1× 103 0.5× 141 2.2k
Carole Lunny Canada 20 277 0.5× 139 0.4× 304 1.0× 364 1.3× 251 1.1× 58 1.7k
Edward P. Armstrong United States 27 184 0.4× 363 1.1× 17 0.1× 319 1.1× 511 2.3× 149 2.9k

Countries citing papers authored by Rafael Dal‐Ré

Since Specialization
Citations

This map shows the geographic impact of Rafael Dal‐Ré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Dal‐Ré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Dal‐Ré more than expected).

Fields of papers citing papers by Rafael Dal‐Ré

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Dal‐Ré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Dal‐Ré. The network helps show where Rafael Dal‐Ré may publish in the future.

Co-authorship network of co-authors of Rafael Dal‐Ré

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Dal‐Ré. A scholar is included among the top collaborators of Rafael Dal‐Ré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Dal‐Ré. Rafael Dal‐Ré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dal‐Ré, Rafael, et al.. (2025). Patient and public involvement in registered non-pharmacological non-commercial Spanish trials completed in 2009–2024: A systematic review. Medicina Clínica. 165(1). 106964–106964. 1 indexed citations
3.
Dal‐Ré, Rafael. (2024). Current policies of non‐commercial funders towards transparency in clinical trials. European Journal of Clinical Investigation. 54(6). e14187–e14187.
4.
Dal‐Ré, Rafael, Arthur L. Caplan, Søren Holm, Reecha Sofat, & Richard Stephens. (2024). Adequate information about clinical trial results must be given to participants. Nature Medicine. 30(9). 2404–2406. 2 indexed citations
5.
Dal‐Ré, Rafael, Rita Banzi, Ioana A. Cristea, et al.. (2023). Using the phases of clinical development of medicines to describe clinical trials assessing other interventions is widespread but not useful. Journal of Clinical Epidemiology. 161. 157–163. 2 indexed citations
6.
Dal‐Ré, Rafael & Ignacio Mahíllo. (2023). Posting of clinical trial results and other critical information from completed medicines trials on ClinicalTrials.gov. European Journal of Clinical Pharmacology. 79(10). 1385–1390. 5 indexed citations
7.
Dal‐Ré, Rafael. (2022). The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humans. Therapies. 78(3). 293–302. 3 indexed citations
8.
Dal‐Ré, Rafael, Walter A. Orenstein, & Arthur L. Caplan. (2021). Being fair to participants in placebo-controlled COVID-19 vaccine trials. Nature Medicine. 27(6). 938–938.
9.
Dal‐Ré, Rafael, L.M. Bouter, Pim Cuijpers, Christian Gluud, & Søren Holm. (2020). Should research misconduct be criminalized?. Research Ethics. 16(1-2). 1–12. 44 indexed citations
10.
Dal‐Ré, Rafael, Arthur L. Caplan, & Ana Marušić. (2019). Editors’ and authors’ individual conflicts of interest disclosure and journal transparency. A cross-sectional study of high-impact medical specialty journals. BMJ Open. 9(7). e029796–e029796. 23 indexed citations
11.
Dal‐Ré, Rafael & Carmen Ayuso. (2019). Reasons for and time to retraction of genetics articles published between 1970 and 2018. Journal of Medical Genetics. 56(11). 734–740. 28 indexed citations
12.
Dal‐Ré, Rafael. (2019). Análisis de los artículos españoles de biomedicina retractados entre 1970 y 2018. Medicina Clínica. 154(4). 125–130. 3 indexed citations
13.
Dal‐Ré, Rafael. (2019). Transparencia de las revistas españolas de medicina hacia sus lectores y autores. Anales de Pediatría. 91(1). 67–70. 2 indexed citations
14.
Almoguera, Berta, Rosa Riveiro-Álvarez, Jorge López‐Castromán, et al.. (2012). Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population. The Pharmacogenomics Journal. 13(2). 197–204. 20 indexed citations
15.
Dal‐Ré, Rafael. (2005). El dictamen único en los ensayos clínicos multicéntricos: la nueva normativa española en el entorno europeo. Medicina Clínica. 124(7). 263–265. 2 indexed citations
16.
García‐Puig, Juan, et al.. (2004). PREVALENCE OF CARBOHYDRATE METABOLIC ALTERATIONS IN HOSPITAL-BASED HYPERTENSION UNITS IN SPAIN. Journal of Hypertension. 22(Suppl. 1). S97–S97. 3 indexed citations
17.
18.
Luque, A., et al.. (2004). Lack of Pharmacologic Interaction Between Paroxetine and Alprazolam at Steady State in Healthy Volunteers. Journal of Clinical Psychopharmacology. 24(3). 268–276. 17 indexed citations
19.
20.
Dal‐Ré, Rafael, et al.. (1996). Encuesta seriada de prevalencia de anticuerpos anti-VHA en adolescentes de un área urbana: estudio comparativo (1990-1995). Atención Primaria. 18(10). 584–585. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine D. DeAngelis Breakdown of academic impact, for papers by Iain Chalmers Breakdown of academic impact, for papers by Dale McLerran Breakdown of academic impact, for papers by Aneesa Motala Breakdown of academic impact, for papers by Eugène van Puijenbroek Breakdown of academic impact, for papers by Antje Timmer Breakdown of academic impact, for papers by Kirsty Loudon Breakdown of academic impact, for papers by Allen F. Shaughnessy Breakdown of academic impact, for papers by Carole Lunny Breakdown of academic impact, for papers by Edward P. Armstrong
Rankless by CCL
2026